Baijiayun Group (RTC) shares were up 66% in recent Thursday premarket activity, after it said overnight it partnered with Beijing Xinlantian Education Technology to create artificial intelligence-driven rehabilitation programs for children with autism.
UniQure (QURE) stock jumped more than 49% after saying its experimental gene therapy, AMT-130, received breakthrough therapy designation from the US Food and Drug Administration to treat Huntington's disease.
Eli Lilly (LLY) shares rose 13%, after the drug manufacturer said its drug orforglipron met primary and secondary endpoints compared with a placebo in a phase 3 trial evaluating its safety and efficacy in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.
Kosmos Energy (KOS) stock was 7.2% higher after the company and BP (BP) said that the first cargo of liquefied natural gas from the Greater Tortue Ahmeyim project, offshore Mauritania and Senegal, has been loaded.
Charles Schwab (SCHW) shares advanced over 4% after it posted higher Q1 adjusted earnings and net revenue from a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.